{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:13:42Z","timestamp":1792790022320,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00277-022-04964-y","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T18:03:54Z","timestamp":1661537034000},"page":"2307-2315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Amyloidosis and COVID-19: experience from an amyloid program in Canada"],"prefix":"10.1007","volume":"101","author":[{"given":"Ellen","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nowell","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J. H.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Chhibber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Mahe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"McCulloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Bahlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9294-9437","authenticated-orcid":false,"given":"Victor H.","family":"Jimenez-Zepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"4964_CR1","unstructured":"Coronavirus disease 2019 (COVID-19) situation report-51. World Health Organization. March 11, 2020. Accessed April 15, 2022. 20200311-sitrep-51-covid-19.pdf (who.int)"},{"key":"4964_CR2","unstructured":"WHO Coronavirus (COVID-19) Dashboard. World Health Organization. Accessed April 15, 2022. WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data"},{"key":"4964_CR3","unstructured":"COVID-19 Alberta Statistics: interactive aggregate data on COVID-19 cases in Alberta. Government of Alberta. Updated April 4, 2022. Accessed April 15, 2022. COVID-19 Alberta statistics | alberta.ca"},{"key":"4964_CR4","doi-asserted-by":"publisher","unstructured":"Beaumont AL, Vignes D, Sterpu R, et al. Factors associated with hospital admission and adverse outcome for COVID-19: role of social factors and medical care [published online ahead of print, 2022 Feb 13].\u00a0Infect Dis Now. 2022;S2666\u20139919(22)00032-X. https:\/\/doi.org\/10.1016\/j.idnow.2022.02.001","DOI":"10.1016\/j.idnow.2022.02.001"},{"issue":"13","key":"4964_CR5","doi-asserted-by":"publisher","first-page":"12493","DOI":"10.18632\/aging.103579","volume":"12","author":"X Fang","year":"2020","unstructured":"Fang X, Li S, Yu H et al (2020) Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging (Albany NY) 12(13):12493\u201312503. https:\/\/doi.org\/10.18632\/aging.103579","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"4964_CR6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMra023144","volume":"349","author":"G Merlini","year":"2003","unstructured":"Merlini G, Bellotti V (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349(6):583\u2013596. https:\/\/doi.org\/10.1056\/NEJMra023144","journal-title":"N Engl J Med"},{"issue":"4","key":"4964_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","volume":"27","author":"MD Benson","year":"2020","unstructured":"Benson MD, Buxbaum JN, Eisenberg DS et al (2020) Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 27(4):217\u2013222. https:\/\/doi.org\/10.1080\/13506129.2020.1835263","journal-title":"Amyloid"},{"key":"4964_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/bjh.16898","volume":"190","author":"E Kastritis","year":"2020","unstructured":"Kastritis E, Wechalekar A, Sch\u00f6nland S, Sanchorawala V, Merlini G, Palladini G, Minnema M, Roussel M, Jaccard A, Hegenbart U, Kumar S, Cibeira MT, Blade J, Dimopoulos MA (2020) Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic. Br J Haematol 190:346\u2013357. https:\/\/doi.org\/10.1111\/bjh.16898","journal-title":"Br J Haematol"},{"issue":"18","key":"4964_CR9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708\u20131720","journal-title":"N Engl J Med"},{"issue":"1","key":"4964_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13023-021-01834-0","volume":"16","author":"TH Brannagan 3rd","year":"2021","unstructured":"Brannagan TH 3rd, Auer-Grumbach M, Berk JL et al (2021) ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable. Orphanet J Rare Dis 16(1):204","journal-title":"Orphanet J Rare Dis"},{"issue":"22","key":"4964_CR11","doi-asserted-by":"publisher","first-page":"5809","DOI":"10.1158\/1078-0432.CCR-20-2989","volume":"26","author":"A Broom","year":"2020","unstructured":"Broom A, Kenny K, Page A, Cort N, Lipp ES, Tan AC, Ashley DM, Walsh KM, Khasraw M (2020) The paradoxical effects of COVID-19 on cancer care: current context and potential lasting impacts. Clin Cancer Res. 26(22):5809\u20135813. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2989","journal-title":"Clin Cancer Res."},{"issue":"25","key":"4964_CR12","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1182\/blood.2020008824","volume":"136","author":"A Vijenthira","year":"2020","unstructured":"Vijenthira A, Gong IY, Fox TA et al (2020) Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood 136(25):2881\u20132892. https:\/\/doi.org\/10.1182\/blood.2020008824","journal-title":"Blood"},{"issue":"2","key":"4964_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100403","volume":"7","author":"C Buske","year":"2022","unstructured":"Buske C, Dreyling M, Alvarez-Larr\u00e1n A et al (2022) Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA interdisciplinary expert consensus. ESMO Open 7(2):100403. https:\/\/doi.org\/10.1016\/j.esmoop.2022.100403","journal-title":"ESMO Open"},{"issue":"13","key":"4964_CR14","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1056\/NEJM199709253371306","volume":"337","author":"RH Falk","year":"1997","unstructured":"Falk RH, Comenzo RL, Skinner M (1997) The systemic amyloidoses. N Engl J Med 337(13):898\u2013909","journal-title":"N Engl J Med"},{"issue":"12","key":"4964_CR15","doi-asserted-by":"publisher","first-page":"E475","DOI":"10.1002\/ajh.26373","volume":"96","author":"N Schiller Salton","year":"2021","unstructured":"Schiller Salton N, Szwarcwort M, Tzoran I et al (2021) Attenuated humoral immune response following anti-SARS-CoV-2 vaccine in heavily pretreated patients with multiple myeloma and AL amyloidosis. Am J Hematol 96(12):E475\u2013E478. https:\/\/doi.org\/10.1002\/ajh.26373","journal-title":"Am J Hematol"},{"issue":"8","key":"4964_CR16","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ccell.2021.07.001","volume":"39","author":"EA Griffiths","year":"2021","unstructured":"Griffiths EA, Segal BH (2021) Immune responses to COVID-19 vaccines in patients with cancer: promising results and a note of caution. Cancer Cell 39(8):1045\u20131047. https:\/\/doi.org\/10.1016\/j.ccell.2021.07.001","journal-title":"Cancer Cell"},{"issue":"6","key":"4964_CR17","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","volume":"116","author":"L Chen","year":"2020","unstructured":"Chen L, Li X, Chen M, Feng Yi, Xiong C (2020) The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res 116(6):1097\u20131100. https:\/\/doi.org\/10.1093\/cvr\/cvaa078","journal-title":"Cardiovasc Res"},{"key":"4964_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","volume":"28","author":"Y Xie","year":"2022","unstructured":"Xie Y, Xu E, Bowe B et al (2022) Long-term cardiovascular outcomes of COVID-19. Nat Med 28:583\u2013590. https:\/\/doi.org\/10.1038\/s41591-022-01689-3","journal-title":"Nat Med"},{"issue":"8","key":"4964_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/s1470-2045(20)30388-0","volume":"21","author":"Camille Maringe","year":"2021","unstructured":"Maringe Camille, Spicer James, Morris Melanie et al (2021) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: A national, population-based, modelling study. Lancet Oncol 21(8):1023\u20131034. https:\/\/doi.org\/10.1016\/s1470-2045(20)30388-0","journal-title":"Lancet Oncol"},{"issue":"8","key":"4964_CR20","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.annonc.2020.05.00","volume":"31","author":"A Sud","year":"2020","unstructured":"Sud A, Jones ME, Broggio J et al (2020) Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol 31(8):1065\u20131074. https:\/\/doi.org\/10.1016\/j.annonc.2020.05.00","journal-title":"Ann Oncol"},{"issue":"2","key":"4964_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40271-017-0273-5","volume":"11","author":"KL McCausland","year":"2018","unstructured":"McCausland KL, White MK, Guthrie SD et al (2018) Light Chain (AL) Amyloidosis: the journey to diagnosis. Patient 11(2):207\u2013216. https:\/\/doi.org\/10.1007\/s40271-017-0273-5","journal-title":"Patient"},{"issue":"7","key":"4964_CR22","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","volume":"79","author":"RA Kyle","year":"1992","unstructured":"Kyle RA, Linos A, Beard CM, Linke RP, Gertz MA, O\u2019Fallon WM et al (1992) Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood. 79(7):1817\u201322","journal-title":"Blood."},{"issue":"4","key":"4964_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/bjh.12286","volume":"161","author":"JH Pinney","year":"2013","unstructured":"Pinney JH, Smith CJ, Taube JB, Lachmann HJ, Venner CP, Gibbs SD et al (2013) Systemic amyloidosis in England: an epidemiological study. Br J Haematol 161(4):525\u2013532","journal-title":"Br J Haematol"},{"issue":"2","key":"4964_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40119-019-0142-5","volume":"8","author":"I Winburn","year":"2019","unstructured":"Winburn I, Ishii T, Sumikawa T, Togo K, Yasunaga H (2019) Estimating the prevalence of transthyretin amyloid cardiomyopathy in a large in-hospital database in Japan. Cardiol Ther 8(2):297\u2013316. https:\/\/doi.org\/10.1007\/s40119-019-0142-5","journal-title":"Cardiol Ther"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04964-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04964-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04964-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T06:07:36Z","timestamp":1662703656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04964-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["4964"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04964-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"assertion":[{"value":"5 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for the review of these records was obtained from the TBCC Institutional Review Board and informed consent was also obtained. This study was performed in accordance with the ethical standards of TBCC research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from patients to participate in this project and our institutional database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Dr. Miller has received research support and consulting fees from Pfizer. Dr. Hahn has received speaker\u2019s fees from Alnylam and Sobi. The remaining authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}